Arca Biopharma | ABIO - Loan Capital


Arca Biopharma reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Alterity Therapeutics Limited AUD 103.21K 73.88K Jun/2023
Amgen USD 50B 2.43B Dec/2025
Arca Biopharma USD 0 0 Mar/2025
Biogen USD 6.29B 1.4M Sep/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Cytokinetics USD 1.12B 957.23M Dec/2025
Daiichi Sankyo JPY 300.15B 199.41B Dec/2025
Gilead Sciences USD 22.14B 5M Sep/2025
GlaxoSmithKline GBP 14.71B 186M Dec/2025
Grifols EUR 10.67B 564.4M Sep/2025
Laboratory Of America USD 5.15B 800K Dec/2025
Myriad Genetics USD 119.5M 60.2M Sep/2025
Otsuka Holdings JPY 166.92B 6.35B Dec/2025
Pfizer USD 57.41B 93M Sep/2025
United Therapeutics USD 100M 100M Jun/2024